Sysmex Corporation

Takayuki Takahata

Yusaku Matsuo

Tatsuru Wakimoto

Yasuhiro Otomo

Kazuki Nakabayashi

Koji Ikeda

Kayo Shoji

Hideki Takata

Mitsuru Taniguchi

Disclosed is a method of using a computer to support an expert meeting for interpretation of genetic information of a patient by a plurality of medical persons, the method including acquiring a test result of gene panel testing that analyzes genetic information of the patient; and outputting an operation screen that enables schedule setting of the expert meeting, based on meeting time according to the test result.

Method for supporting expert meeting by using computer, support device, computer program for supporting expert meeting, and support system

A method of supporting an expert meeting of medical specialists to interpret genetic information, may include: accepting a test request for genetic information on a patient; extracting test progress information that is stored in association with the accepted test request and indicates progress of a test for the test request, and schedule information on a schedule of the expert meeting to interpret the genetic information obtained in the test for the test request; and displaying the extracted test progress information and the extracted schedule information on terminal devices of the medical specialists.

Method of supporting interpretation of genetic information by medical specialist, information management system, and integrated data management device

A method of supporting an expert meeting of medical specialists to interpret genetic information, may include: accepting a schedule of the expert meeting; extracting the medical specialists to participate in the expert meeting, the medical specialists stored in association with the accepted schedule of the expert meeting; and transmitting the accepted schedule of the expert meeting to terminal devices of the extracted medical specialists.

The present invention provides a novel marker capable of accurately diagnosing the lymph node metastasis of stomach cancer. An mRNA, or a fragment thereof, coding for at least one protein selected from TFF1, AGR2, PRSS8, MUC1, MUC4 and MUC17 can be useful as a lymph node metastasis marker.

Growing community of inventors

Kobe, Japan

Takayuki Takahata